Investor Presentaiton

Health Care 2-2-2. Healthcare Solutions THE KAITEKI COMPANY ■Aiming for net sales of ¥300 billion and operating income of ¥30 billion in fiscal 2020, strengthen existing businesses, work in concert with other Group companies, and develop/promote new growth businesses through alliances and innovation (Sales forecast for fiscal 2014: Approx. ¥130 billion) ■Strengthen existing businesses QKK • Expand capsule business, new production lines under construction APIC • Strengthen manufacturing of API for use in generics LSIM • Expand sales of new testing kits, restructure systems for developing PATHFAST diagnostic equipment in U.S.A. HLC • • Expand number of drugstores providing services for the self-health check service Jibun Karada Club by eliminating the grey zone (Looking to reach 1,000 drugstores in fiscal 2015) Promote initiatives to make use of ICT for next-generation healthcare services* *Effective disease prevention, health maintenance, life support services related to diseases, etc., and diverse forms of evidence-based healthcare services ■Work in concert with other Group companies, conclude alliances, and innovate • • • Realize synergies with the MCHC Group (development of new capsule materials, develop diagnostic reagents, etc.) Form alliances with academia (with Kyushu University and Tsinghua University (Beijing) in the clinical testing field) Form alliances with other companies (operating agreement with Nikon Corporation in the testing and diagnostic equipment fields) • Promote alliances in the regenerative medicine field Mitsubishi Chemical Holdings 19

View entire presentation